Literature DB >> 870610

[Enzymatic determination of total cholesterol with the Greiner Selective Analyzer (GSA-II) (author's transl)].

K Borner, S Klose.   

Abstract

A fully enzymatic method to determine total cholesterol in serum is described. The method appears especially suitable for adaptation to discrete mechanical analyzers either of the single channel or the multi-channel type. The method uses the enzymes cholesterol esterase (EC 3.1.1.13), cholesterol oxidase (EC 1.1.3.6) and peroxidase (EC 1.11.1.7) with 4-aminophenazone and phenol as substrates in the indicator reaction. The method was adapted to the Greiner Selective Analyzer GSA-II. For this purpose the critical parameters of the reaction were intensively examined. The complete reagent is stable within the GSA II dispenser at 4 degrees C for at least 1 week. By omitting cholesterol oxidase in the blank reagent a sample bland and a partial reagent blank are obtained. Within a range up to 10.4 mmol/1 (4.0 g/l) the maximum colour is developed within 6 minutes. The calibration factor was stable for 4 months. The method allows absolute measurements. At concentrations between 2 and 4 mmol/1 within-batch precision ranged from 0.5 to 1.4%. Precision from day to day for the same control sera amounted to 2.8; 2.0; 2.7 and 2.0% for a period of 3 months. Examination of accuracy yielded satisfying results. Ascorbic acid in the physiological range did not alter results to a significant extent. Catalase or novaminesulfone added in vitro did not interfere. Optical interferences by bilirubin, hemoglobin or turbidity are compensated by a sample blank. A comparison of results with the enzymatic method of Roeschlau et al. (Z. Klin. Chem. Klin. Biochem. 12, 226 (1974)) yielded satisfactory agreement. The limits of detection of the present method can be lowered by a factor of 2.2 by replacing phenol by dihalogen phenols.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870610

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  11 in total

1.  Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients.

Authors:  Giuseppe Derosa; Arrigo F G Cicero; Anna Carbone; Fabrizio Querci; Elena Fogari; Angela D'Angelo; Pamela Maffioli
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

2.  Plasma cholesterol and related lipid levels of seemingly healthy public service employees in Kampala, Uganda.

Authors:  G S Bimenya; J K Okot; H Nangosa; S A Anguma; W Byarugaba
Journal:  Afr Health Sci       Date:  2006-09       Impact factor: 0.927

3.  Familial hypobetalipoproteinaemia in 9 children diagnosed as the result of cord blood screening for hypolipoproteinaemia in 10 000 Danish newborns.

Authors:  G E Andersen; K Brokhattingen; P Lous
Journal:  Arch Dis Child       Date:  1979-09       Impact factor: 3.791

4.  Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance.

Authors:  Giuseppe Derosa; Arrigo F G Cicero; Angela D'Angelo; Pietro D Ragonesi; Leonardina Ciccarelli; Elena Fogari; Sibilla A T Salvadeo; Ilaria Ferrari; Alessia Gravina; Raffaella Fassi; Roberto Fogari
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

5.  Safety and Efficacy of Alpha Lipoic Acid During 4 Years of Observation: A Retrospective, Clinical Trial in Healthy Subjects in Primary Prevention.

Authors:  Giuseppe Derosa; Angela D'Angelo; Paola Preti; Pamela Maffioli
Journal:  Drug Des Devel Ther       Date:  2020-12-03       Impact factor: 4.162

6.  Adipocytokine levels in obese and non-obese subjects: an observational study.

Authors:  Giuseppe Derosa; Elena Fogari; Angela D'Angelo; Lucio Bianchi; Aldo Bonaventura; Davide Romano; Pamela Maffioli
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

7.  Oral fat load effects on inflammation and endothelial stress markers in healthy subjects.

Authors:  Giuseppe Derosa; Ilaria Ferrari; Angela D'Angelo; Sibilla A T Salvadeo; Elena Fogari; Alessia Gravina; Roberto Mereu; Ilaria Palumbo; Pamela Maffioli; Sabrina Randazzo; Arrigo F G Cicero
Journal:  Heart Vessels       Date:  2009-05-24       Impact factor: 2.037

8.  Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques.

Authors:  Per-Arne Svensson; Mikael C O Englund; Magnus S C Snäckestrand; Daniel A Hägg; Bertil G Ohlsson; Veronika Stemme; Lillemor Mattsson-Hulten; Dag S Thelle; Björn Fagerberg; Olov Wiklund; Lena M S Carlsson; Björn Carlsson
Journal:  BMC Cardiovasc Disord       Date:  2005-08-25       Impact factor: 2.298

9.  Short-term effects of a combined nutraceutical of insulin-sensitivity, lipid level and indexes of liver steatosis: a double-blind, randomized, cross-over clinical trial.

Authors:  Arrigo F G Cicero; Martina Rosticci; Angelo Parini; Martino Morbini; Riccardo Urso; Elisa Grandi; Claudio Borghi
Journal:  Nutr J       Date:  2015-03-28       Impact factor: 3.271

10.  Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study.

Authors:  Giuseppe Derosa; Angela D'Angelo; Pamela Maffioli
Journal:  Drug Des Devel Ther       Date:  2019-10-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.